Literature DB >> 26681683

The GILDA trial finds no survival benefit from intensified screening after primary resection of colorectal cancer: the PulMiCC trial tests the survival benefit of pulmonary metastasectomy for detected asymptomatic lung metastases.

T Treasure1, F Macbeth2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26681683     DOI： 10.1093/annonc/mdv618

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

Review 1.  Surveillance after curative treatment for colorectal cancer.

Authors:  Eric P van der Stok; Manon C W Spaander; Dirk J Grünhagen; Cornelis Verhoef; Ernst J Kuipers
Journal:  Nat Rev Clin Oncol       Date:  2016-12-20       Impact factor: 66.675

Review 2.  Pulmonary metastasectomy: an overview.

Authors:  Francesco Petrella; Cristina Diotti; Arianna Rimessi; Lorenzo Spaggiari
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.